» Articles » PMID: 39076207

Genetic Link Between Mutations and Amyotrophic Lateral Sclerosis: Evidence from Whole-exome Sequencing

Overview
Specialty Geriatrics
Date 2024 Jul 30
PMID 39076207
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Genetics have been shown to have a substantial impact on amyotrophic lateral sclerosis (ALS). The ALS process involves defects in axonal transport and cytoskeletal dynamics. It has been identified that , responsible for encoding a kinesin-3 motor protein that carries synaptic vesicles, is considered a genetic predisposing factor for ALS.

Methods: The analysis of whole-exome sequencing data from 1,068 patients was conducted to examine the genetic link between ALS and . For patients with gene mutations and a family history, we extended the analysis to their families and reanalyzed them using Sanger sequencing for cosegregation analysis.

Results: In our cohort, the mutation frequency was 1.31% (14/1,068). Thirteen nonsynonymous variants were detected in 14 ALS patients. Consistent with the connection between and ALS, the missense mutation p.A1083T (c.3247G>A) was shown to cosegregate with disease. The mutations related to ALS in our study were primarily located in the cargo-binding region at the C-terminal, as opposed to the mutations of motor domain at the N-terminal of which were linked to hereditary peripheral neuropathy and spastic paraplegia. We observed high clinical heterogeneity in ALS patients with missense mutations in the gene. is a more frequent determinant of ALS in the European population, while accounts for a similar proportion of ALS in both the European and Chinese populations.

Conclusion: Our investigation revealed that mutations in the C-terminus of could increase the risk of ALS, support the pathogenic role of in ALS and expand the phenotypic and genetic spectrum of -related ALS.

References
1.
Goutman S, Hardiman O, Al-Chalabi A, Chio A, Savelieff M, Kiernan M . Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022; 21(5):465-479. PMC: 9513754. DOI: 10.1016/S1474-4422(21)00414-2. View

2.
Liu X, He J, Chen L, Zhang N, Tang L, Liu X . TBK1 variants in Chinese patients with amyotrophic lateral sclerosis. Neurobiol Aging. 2020; 97:149.e9-149.e15. DOI: 10.1016/j.neurobiolaging.2020.07.028. View

3.
Brooks B, Miller R, Swash M, Munsat T . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001; 1(5):293-9. DOI: 10.1080/146608200300079536. View

4.
Guo W, Naujock M, Fumagalli L, Vandoorne T, Baatsen P, Boon R . HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat Commun. 2017; 8(1):861. PMC: 5636840. DOI: 10.1038/s41467-017-00911-y. View

5.
Baldwin K, Godena V, Hewitt V, Whitworth A . Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum Mol Genet. 2016; 25(12):2378-2392. PMC: 5181624. DOI: 10.1093/hmg/ddw105. View